Successful treatment with adalimumab in infliximab-resistant Crohn's disease

被引：20
|
作者：
Barthel, HR
Gille, T
Halbsguth, A
Kramer, M
机构：
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2005年 / 20卷 / 09期
关键词：
D O I：
10.1111/j.1440-1746.2005.03848.x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1464 / 1465
页数：2
相关论文
共 50 条
  • [41] Comparative Effectiveness of Infliximab and Adalimumab in Crohn's Disease and Ulcerative Colitis
    Ananthakrishnan, Ashwin N.
    Cagan, Andrew
    Cai, Tianxi
    Gainer, Vivian S.
    Shaw, Stanley Y.
    Savova, Guergana
    Churchill, Susanne
    Karlson, Elizabeth W.
    Kohane, Isaac
    Liao, Katherine P.
    Murphy, Shawn N.
    INFLAMMATORY BOWEL DISEASES, 2016, 22 (04) : 880 - 885
  • [42] Comparative Effectiveness of Infliximab and Adalimumab in Crohn's Disease and Ulcerative Colitis
    Ananthakrishnan, Ashwin N.
    Cagan, Andrew
    Cai, Tianxi
    Gainer, Vivian S.
    Shaw, Stanley
    Churchill, Susanne
    Karlson, Elizabeth
    Kohane, Isaac
    Liao, Katherine
    Murphy, Shawn
    GASTROENTEROLOGY, 2016, 150 (04) : S979 - S979
  • [43] Infliximab-Induced Autoimmune Hepatitis with Successful Switch to Adalimumab in a Patient with Crohn’s disease: The Index Case
    Dahlia A. Goldfeld
    Elizabeth C. Verna
    Jay Lefkowitch
    Arun Swaminath
    Digestive Diseases and Sciences, 2011, 56 : 3386 - 3388
  • [44] Letter: are infliximab and adalimumab similar for Crohn's disease in clinical practice?
    Tursi, A.
    Elisei, W.
    Picchio, M.
    Penna, A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (07) : 763 - 764
  • [45] Letter: infliximab and adalimumab in the management of Crohn's disease - are they really comparable?
    Lopez-Sanroman, A.
    Gisbert, J. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (05) : 498 - 499
  • [46] Infliximab-Induced Autoimmune Hepatitis with Successful Switch to Adalimumab in a Patient with Crohn's disease: The Index Case
    Goldfeld, Dahlia A.
    Verna, Elizabeth C.
    Lefkowitch, Jay
    Swaminath, Arun
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (11) : 3386 - 3388
  • [47] Flexural psoriasis induced by infliximab and adalimumab in a patient with Crohn's disease
    Avila Alvarez, A.
    Garcia-Alonso, L.
    Solar Boga, A.
    Garcia-Silva, J.
    ANALES DE PEDIATRIA, 2009, 70 (03): : 278 - 281
  • [48] Elective Switching from Infliximab to Adalimumab in Stable Crohn's Disease
    Hoentjen, Frank
    Haarhuis, Bertram J. T.
    Drenth, Joost P. H.
    de Jong, Dirk J.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (04) : 761 - 766
  • [49] Infliximab vs. Adalimumab for Crohn's disease: authors' reply
    Kaplan, G. G.
    Hur, C.
    Korzenik, J.
    Sands, B. E.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (10) : 1266 - 1267
  • [50] Response to Infliximab After Loss of Response to Adalimumab in Crohn's Disease
    Bauer, Christina M.
    Younis, Adam
    Herfarth, Hans
    Barnes, Edward L.
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (02) : E5 - E5
12345